Skip to content
healthcare.dev

Zilretta

NDC 65250-003, triamcinolone acetonide extended-release injectable suspension, kit, from Pacira Pharmaceuticals, Inc..

Product NDC
65250-003
Status
Listed
Labeler
Pacira Pharmaceuticals, Inc.
Dosage form
KIT
Route
INTRA-ARTICULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208845
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65250-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
65250-003-01652500003011 KIT in 1 CARTON (65250-003-01) * 1 INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE in 1 VIAL, SINGLE-DOSE (65250-001-01) * 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE (65250-002-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cd5c4673-21f2-4126-9556-da847b3a228b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65250-003

Use it

Look up 65250-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65250-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65250-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.